Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
for
Sudan Virus Disease
Location: Boston MA, Washington D.C. DC, Lenexa KS
Sponsor: International AIDS Vaccine Initiative
Sex: All
Age: 18 - 50
Code: NCT07565090
Phase 1, Recruiting
Defibrotide for the Treatment of Severe COVID-19
for
Covid19
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18 - 70+
Code: NCT04652115
Phase 2, Recruiting
Finding Links Between Hot flASHes and CardioVascular Disease
for
Menopause-related Hot Flashes
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: Female
Age: 40 - 65
Code: NCT07077395
Phase 2, Recruiting
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
for
Refractory Autoimmune Diseases
Location: Boston MA, Durham NC
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT07115745
Phase 1, Recruiting
Deceased Uterine Transplant in Absolute Uterine Infertility (AUIF)
for
Infertility of Uterine Origin
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: Female
Age: 18 - 40
Code: NCT04026893
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
for
Vitiligo, Non-Segmental Vitiligo (NSV)
Location: Boston MA, Portsmouth NH, The Bronx NY, Verdun, Ottawa,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07533019
Phase 2, Recruiting
Descartes-08 in Autoantibody Myositis
for
Antisynthetase Syndrome
Location: Boston MA, Chapel Hill NC, Austin TX, Orange CA
Sponsor: Cartesian Therapeutics
Sex: All
Age: 18+
Code: NCT07391605
Phase 2, Recruiting
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma